Insights

Type Clear all

Select all that apply

Topic Clear all

Select all that apply

icons/content-types/video webinar

This webinar will explore the specific requirements for industrializing processes in the production of ionizable lipids and PEG lipids, elucidating concepts to address typical challenges.

icons/content-types/video webinar

In this podcast, we will explore the advantages of partnering with a Contract Development and Manufacturing Organization (CDMO) to navigate the journey from molecule conception to clinical trials, including the expertise, experience, and preparedness...

icons/content-types/video webinar

In this GEN webinar, Scott Alderucci will discuss ways of leveraging new technologies and experimental design for an optimized, tailored approach to mRNA therapy development.

icons/content-types/article article

Significant changes have taken place in the life sciences industry over the past few years. Since the Covid-19 pandemic, the U.S. government has urged biotech and pharmaceutical companies to increase domestic production in order to secure the drug su...

icons/content-types/video webinar

The COVID-19 pandemic brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links and re-igniting discussions around the value of reshoring production. In this webinar we will discuss drivers to consider i...

icons/content-types/video webinar

This webinar will provide a general overview of mRNA therapeutics design and production and discuss the importance of robust quality systems in the context of GMP production of mRNA therapeutics.

icons/content-types/article article

February 28 marks the global observance of Rare Disease Day, a day when we participate in raising awareness and generating change for the global population and their families living with rare diseases.

icons/content-types/fact sheet fact sheet

Partner with Curia for combined expertise, speed and reliability to support the research, development and manufacturing of your mRNA product.

icons/content-types/infographic infographic

We offer a robust portfolio of market-leading APIs and world-class capabilities in niche and high-barrier-to-entry technologies.

icons/content-types/article article

For many who are new to drug development, the greatest challenge is not necessarily discovering a blockbuster molecule—it’s finding a team capable of carrying that molecule through the complexities that lie between the research lab and the patien...

icons/utility/left caret 1 icons/utility/right caret